-
α-KG, LKB1-AMPK, and Periodontal Stem-Cell Senescence
2026-09-08
The reference study identifies an α-ketoglutarate–LKB1-AMPK axis that restores mitochondrial homeostasis and limits inflammation-induced senescence in human periodontal ligament stem cells. Its combination of mitochondrial, senescence, osteogenic, pharmacological, and animal-model evidence provides a mechanistic framework for studying periodontal regeneration under inflammatory stress.
-
MPC, Lactate, and Histone Lactylation in CRC
2026-09-07
The 2025 reference study identifies a metabolic–epigenetic–immune pathway in colorectal cancer: reduced MPC1/MPC2 activity increases lactate, elevates histone lactylation in dendritic cells, and weakens CD8+ T-cell responses. Its experiments connect mitochondrial pyruvate handling with dendritic-cell maturation and anti-PD-1 efficacy, while also defining important limits for translating the findings to other lactate-centered research systems.
-
Thymosin-β4 and Notch/NF-κB in Limb Ischemia
2026-09-05
A 2020 study linked thymosin-β4 overexpression with improved endothelial angiogenic behavior and activation of the Notch/NF-κB axis in critical limb ischemia models. Its combined cell, animal, inhibitor, and molecular readouts provide a useful framework for studying pathway-dependent neovascularization while highlighting the limits of overexpression and pharmacological evidence.
-
DAPI Solution (1 mg/mL): Reliable Apoptosis Staining
2026-09-05
Learn how DAPI Solution (1 mg/mL), SKU K2401, supports reproducible nuclear visualization, viability assessment, and apoptosis-oriented workflows in microscopy and flow cytometry. This scenario-based guide covers assay design, controls, interpretation, protocol parameters, and practical vendor-selection criteria.
-
Recombinant Human Oncostatin M in Fibroblast Assays
2026-09-04
Recombinant Human Oncostatin M provides a defined cytokine perturbation for studying fibroblast proliferation, inflammatory signaling, and senescence-associated phenotypes. This article connects rh-Oncostatin M assay design with mitochondrial-quality measurements from a 2025 dermal fibroblast study, while clearly separating established evidence from new experimental hypotheses.
-
Octenidine Dihydrochloride Research Workflows
2026-09-04
Build reproducible membrane-disruption, planktonic, and biofilm assays around Octenidine dihydrochloride while controlling solubility, adsorption, and endpoint bias. The compound is also a practical benchmark for evaluating next-generation gemini quaternary ammonium compounds, provided that derivative performance is not assumed to transfer automatically.
-
MK0787 Versus New β-Lactams: 1982 Evidence
2026-09-03
Cullmann and colleagues evaluated N-formimidoyl thienamycin (MK0787) against a broad panel of resistant clinical isolates and compared it directly with several emerging β-lactam antibiotics, including Cefoperazone. The study’s main contribution was to connect organism-specific MIC patterns, bactericidal activity, and β-lactamase independence in a standardized in vitro framework that remains useful for interpreting comparative antimicrobial data.
-
EV-Transferred ACLY Drives TAM Differentiation in HCC
2026-09-03
The reference study identifies extracellular vesicle transfer of ATP-citrate lyase as a metabolic mechanism that converts monocytes into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its engineered CD81-decorated liposomal system provides a targeted strategy for blocking this axis and improving anti-PD-1/PD-L1 activity.
-
Stiripentol LDH Inhibitor: Research Workflows
2026-09-02
Stiripentol is a chemically distinct LDH inhibitor for controlled studies of lactate flux, astrocyte-neuron lactate shuttle modulation, and seizure biology. Its pharmacological action also provides a hypothesis-generating tool for testing how lactate metabolism and histone lactylation influence dendritic-cell and CD8+ T-cell function in colorectal cancer models.
-
BI 2536 for Reliable PLK1 Cell Assays
2026-09-02
BI 2536 (SKU A3965) offers a potent, selective PLK1 perturbation tool for interpreting proliferation, cell-cycle arrest, and apoptosis in cancer research. This scenario-based guide connects formulation, assay design, data interpretation, and vendor selection to improve the clarity and comparability of cell-based experiments.
-
Plant Cell Lysis Buffer: Native Protein Workflow
2026-09-01
Build a cold, reproducible workflow for extracting plant proteins while retaining phosphorylation states and native protein interactions. This guide connects Western blotting, immunoprecipitation, co-IP, and ELISA decisions to the MAPK10–KRT16 research framework without confusing published cancer findings with product-specific validation.
-
Perphenazine: D2 Antagonist Research Guide
2026-08-31
Perphenazine is a dopamine D2 receptor antagonist with additional histamine, muscarinic, and adrenergic receptor activity. Research data support its use in schizophrenia research, mitochondria-mediated cell death induction, opioid tolerance suppression, and exploratory host-directed antibacterial studies.
-
Perphenazine: Research Workflows and Applications
2026-08-31
Perphenazine combines dopamine D2 receptor antagonism with broader phenothiazine receptor activity, enabling integrated neuropharmacology, mitochondrial, and host-directed immunity studies. This practical guide translates published findings into assay design, control selection, and troubleshooting strategies for reproducible research use.
-
Pemetrexed Workflows for Tumor Cell Research
2026-08-30
Build reproducible Pemetrexed dose–response assays around folate-pathway biology, controlled exposure, and phenotype-resolved readouts. The workflow also shows how pemetrexed disodium can support malignant mesothelioma model studies that incorporate DNA-repair status without overinterpreting combination-treatment results.
-
Patient-Derived Gastric Cancer Assembloids
2026-08-29
The reference study introduces gastric cancer assembloids that combine patient-matched tumor organoids with stromal subpopulations, producing a model that better reflects tumor heterogeneity and microenvironmental signaling. Its transcriptomic and drug-response results show that stromal context can reshape inflammatory programs, extracellular-matrix remodeling, and therapeutic sensitivity, supporting more informative personalized cancer biology research.